Clinical Trial Update: FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for intramuscular FGF-1 in peripheral arterial disease has phases 1 and 2, with unspecified status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Arterial Disease
• Stenosis

Drugs mentioned

• FGF-1 (fibroblast growth factor 1)

Snippet

Sponsor: CardioVascular BioTherapeutics, Inc. | Conditions: Peripheral Arterial Disease, Stenosis | Phase 1, Phase 2 | Status: UNKNOWN